Can-Fite BioPharma Ltd.
CANF | TA
Overview
Corporate Details
- ISIN(s):
- IL0010944739 (+2 more)
- LEI:
- 549300ZLRH6GSBOHFZ59
- Country:
- Israel
- Address:
- PO BOX 7537, 4917000 PETACH-TIKVA
- Website:
- https://www.canfite.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Can-Fite BioPharma Ltd. develops advanced therapies for cancer and inflammatory diseases.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-01 01:14 |
Regulatory News Service
Other Report or Announcement
|
English | 102.5 KB | |
| 2025-07-01 01:14 |
Regulatory News Service
Other Report or Announcement
|
English | 36.9 KB | |
| 2025-06-24 01:15 |
Takeover Announcement Report
Annual General Meeting was adjourned for June 30, 2025 due to lack of quorum
|
English | 101.0 KB | |
| 2025-06-24 01:15 |
Regulatory News Service
Annual General Meeting was adjourned for June 30, 2025 due to lack of quorum
|
English | 36.9 KB | |
| 2025-06-16 18:00 |
Takeover Announcement Report
Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnerin…
|
English | 145.0 KB | |
| 2025-06-16 18:00 |
Regulatory News Service
Can-Fite to Present Phase IIa Pancreatic Cancer Study Progress During Partnerin…
|
English | 36.6 KB | |
| 2025-05-17 01:36 |
Regulatory News Service
Immediate Report of Meeting
|
English | 997.4 KB | |
| 2025-05-17 01:36 |
Regulatory News Service
Immediate Report of Meeting
|
English | 997.4 KB | |
| 2025-05-17 01:36 |
Declaration of Voting Results & Voting Rights Announcements
Immediate Report of Meeting
|
English | 120.4 KB | |
| 2025-05-10 01:30 |
Prospectus
ATM Prospectus Supplement
|
English | 131.1 KB | |
| 2025-05-10 01:30 |
Regulatory News Service
ATM Prospectus Supplement
|
English | 36.5 KB | |
| 2025-05-05 17:00 |
Regulatory News Service
Can-Fite Has Raised $175 Million in Total to Date for the Development of Namode…
|
English | 135.4 KB | |
| 2025-05-05 17:00 |
Regulatory News Service
Can-Fite Has Raised $175 Million in Total to Date for the Development of Namode…
|
English | 36.6 KB | |
| 2025-04-17 18:23 |
Regulatory News Service
Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite…
|
English | 120.9 KB | |
| 2025-04-17 18:23 |
Regulatory News Service
Following FDA Compassionate Use Approval for Pancreatic Carcinoma with Can-Fite…
|
English | 36.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |